Skip to main content
. 2014 Mar 31;6:37–45. doi: 10.2147/DHPS.S43304

Figure 5.

Figure 5

SVR12 rates in patients with HCV genotype 1: LONESTAR study results.

Notes: Results from treatment-naïve and treatment-experienced patients with and without cirrhosis, treated with SOF + LDV for 8 weeks or 12 weeks, with or without RBV.33

Abbreviations: HCV, hepatitis C virus; LDV, ledipasvir; RBV, ribavirin; SOF, sofosbuvir; SVR12, sustained virologic response rate 12 weeks after treatment.